My personal Substack
| Platform |  | Pricing | Freemium | Publishes | Twice weekly |
|---|---|---|---|---|---|
| Issues | 85 | Founded | 2 years ago | Last Issue | 11 days ago |
| Active | |||||
Read this Newsletter
johncatanzaro.substack.comLatest Issues
STAGE 4 CANCER. 21 WEEKS PREGNANT. GIVEN APPROXIMATELY TWO YEARS TO LIVE.
Stay Tuned: On Dr. Drew’s Health Uncensored, Anna and Jerry report FOUR CLEAR SCANS. 🙏
In 2022, Anna underwent surgery and chemotherapy for stage 2B small-intestinal cancer. She rang the bell.
In 2025, the cancer returned—in her small i...
Transcriptional Shedding: How mRNA Vaccination Can Turn the Recipient into a Source of Harmful Spike Fragments
John’s Substack is a reader-supported publication. To get new posts and support my work, consider subscribing for free or paid access.
Key points
- Transcriptional shedding is not classical viral shedding. mRNA and recombinant COVID...
❓Will the real plague please stand up⁉️
The go-to technology for plague, and for any pandemic threat, is the mRNA platform.
The other vaccine pipelines in development are less appealing for a variety of reasons. So they get passed over.
mRNA Vax preferred. mRNA Vax direct. No...
The Best Business and Health Care Decision for America
Share
The President, the HHS Secretary, and the government agencies under them taking a “neutral stance” on the mRNA technology debacle is beyond negligent. Neutrality at that level is not restraint. It is a decision to keep the harm movin...
Radical Remission
Share
✨🎙️Tune into the latest episode of Radical Remission Project's “Stories that Heal” podcast, featuring John Catanzaro, NMD, PhD - Co-founder of Neo7 Bioscience✨
Dr. John Catanzaro is a pioneering leader in precision molecular medici...
Audience Metrics
Subscribers, engagement, traffic and sponsorship for John’s Substack.
| Subscribers | Engagement | 76 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Dr. John Catanzaro, Co-founder of Neo7Bioscience, merges human intelligence with PBIMA (aHI) technology in molecular bioscience. His 30+ years of experience in molecular technology and personalized peptide engineering, shines on Decision Junction.
Frequently Asked Questions
How can I access the email archive for John’s Substack?
You can find recent issues that have been published by John’s Substack on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does John’s Substack have?
To see how many people subscribe to John’s Substack, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in John’s Substack?
Newsletter advertising can be extremely effective when it's done right. Before you pitch John’s Substack as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like John’s Substack?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact John’s Substack using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to John’s Substack?
Scroll up to where it says Related Newsletters to see other publications like John’s Substack. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact John’s Substack?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.